UAS regulatory sequences drive expression of an RNAi line that targets DCP2.
abnormal locomotor behavior, with Scer\GAL4elav.PU
chemical resistant, with Scer\GAL4elav.PU
Expression of DCP2VDRC.cUa under the control of Scer\GAL4elav.PU confers resistance to chronic nicotine-induced locomotor hyperactivity, and also exhibit higher basal locomotor activity without nicotine treatment, as compared to controls.